688076 Jiangsu Sinopep-Allsino Biopharmaceutical

Watchlist

50.26
-0.03-0.06%

Trading Dec 24 13:28 CST

11.05BMarket Cap26.20P/E (TTM)

About Jiangsu Sinopep-Allsino Biopharmaceutical Company

The company is a biomedical enterprise focusing on polypeptide drugs and small molecule chemicals, combining independent research and development with customized research and development. The company is a national high-tech enterprise and a provincial science and technology enterprise. It was founded in April 2009 and is located in the national Lianyungang Economic and Technological Development Zone. The company was listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange on May 20, 2021. The company is a biomedical enterprise focusing on the combination of independent research and development of polypeptide drugs and small molecule chemicals with customized R&D and production. The company's main products are self-selected products, customized products and technical services.

Company Profile

Short Name-A诺泰生物

Company NameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

Listing DateMay 20, 2021

Issue Price15.57

Shares Offered53.30M share(s)

FoundedApr 3, 2009

Chairmanziquan tong

Legal Representativeziquan tong

General Managerziquan tong

Secretaryhua zhou

Employees1545

ProvinceJiang Su Sheng

Phone0571-86297893

Office AddressRoom 1201, Block E, Hangzhou Normal University Science Park, No. 1378 Wenyi West Road, Yuhang District, Hangzhou

Zip Code311121

Registered AddressNo. 28 Linpu Road, Lianyungang Economic and Technological Development Zone, Jiangsu

Fax0571-86298631

Emailir@sinopep.com

Websitehttp://www.sinopep.com/

Business License913207006871974358

BusinessProduction of freeze-dried powder injections, small-volume injections (including non-final sterilization), raw materials, tablets, hard capsules, health products, and medical devices (all operated according to license approval); research and development of pharmaceutical technology and biotechnology; production of pharmaceutical intermediates and polypeptide intermediates (excluding products involving special approval, such as pharmaceuticals, health products, food, feed, etc.); production and sale of fine chemical products (excluding hazardous chemicals); import and export business of various kinds of commodities and technologies operated by state-limited companies, with the exception of goods and technologies operated by state-restricted companies or prohibited from being imported. (For projects requiring approval according to law, business activities can only be carried out after approval by relevant departments)